#CSLSeqirus
LightNews LightNews
spudislander45.bsky.social
Canada tags #Australia for their vaccine manufacturing.

“This new contract with #CSLSeqirus strengthens #Canada's ability to respond quickly to a potential future flu pandemic,” said Marjorie Michel, Canada’s Minister of Health.
Canada grants vaccine manufacturing contract to CSL Seqirus
The firm promises to produce millions of vaccine doses to in the case of an influenza pandemic.
www.bioprocessintl.com
March 11, 2026 at 12:43 AM
paulnuki.bsky.social
Great to see the @UKHSA stockpiling H5 bird flu vaccine ahead of a possible outbreak.

Here's a story we ran on the @CSLSeqirus (CSLS) factory in Liverpool which makes it a few months ago.

Impressive operation...
www.telegraph.co.uk/global-healt...
The Liverpool vaccine factory preparing for a H5N1 bird flu pandemic
Researchers at the vast facility describe the ‘pre-pandemic’ jabs being made there as a ‘first line of defence’
www.telegraph.co.uk
December 3, 2024 at 10:52 AM
pharmaphorum.bsky.social
An adjuvanted, #trivalent #influenzavaccine developed by #CSLSeqirus and recently approved in the #UK, #Aujemflu, will be deployed ahead of the 2027/28 #fluseason under an agreement with the government.

pharmaphorum.com/news/uk-firs...
UK first country to launch CSL's trivalent flu shot Aujemflu
CSL Seqirus' recently approved trivalent, cell-based influenza vaccine Aujemflu will be part of the UK's 2027/28 immunisation campaign.
pharmaphorum.com
September 22, 2026 at 9:47 AM
catherinefeore.bsky.social
EMA recommends three new medicines and an orphan treatment for rare Rett Syndrome
#CHMP #EMA #Pharmaceuticals #CSLSeqirus #Parkinsons #RettSyndrome
June 29, 2026 at 12:02 PM
vitalsignsnews.bsky.social
EMA recommends three new medicines and an orphan treatment for rare Rett Syndrome
#CHMP #EMA #Pharmaceuticals #CSLSeqirus #Parkinsons #RettSyndrome
www.vitalsigns.news/ema-recommen...
EMA recommends three new medicines and an orphan treatment for rare Rett Syndrome
EMA’s human medicines committee (CHMP) recommended six medicines for approval at its June 2026 meeting
www.vitalsigns.news
June 29, 2026 at 11:56 AM
irat1onal.bsky.social
Lessening The Severity And Impact Of Influenza - Dr. Gregg C Sylvester, MD - Chief Health Officer, CSL Seqirus, joins me on Progress, Potential, And Possibilities #GreggSylvester #CSLSeqirus #Influenza #FluPrevention #Vaccine #FluShot #VaccineAwareness #StayHealthy www.youtube.com/watch?v=OIUy...
Dr. Gregg Sylvester, MD - Chief Health Officer, CSL Seqirus - Lessening The Severity Of Influenza
YouTube video by Progress, Potential, and Possibilities
www.youtube.com
February 27, 2025 at 8:41 PM
vitalsignsnews.bsky.social
Inside EU Health: Inside EU Health: Heat resilience; EMA recommendations; Sanofi disparagement
www.vitalsigns.news/inside-eu-he...
#CHMP #EMA #Pharmaceuticals #CSLSeqirus #Parkinsons #RettSyndrome #Heatwave #Sanofi #Disparagement #Competition #Antitrust
Inside EU Health: Heat resilience; EMA recommendations; Sanofi disparagement
Europe’s deadly heatwave highlights growing climate threat to health; EMA recommends three new medicines and an orphan treatment for rare Rett Syndrome; Commission opens disparagement investigation in...
www.vitalsigns.news
June 29, 2026 at 12:00 PM
4040rec.bsky.social
#pharma #BigPharma #revenuegrowth #drugsales #JohnsonandJohnson #JnJ #AbbVie #EliLilly #Roche #Merck #MSD #Pfizer #Sanofi #Novartis #AstraZeneca #GSK #Takeda #GileadSciences #CSL #CSLSeqirus #Bayer #BoehringerIngelheim #Amgen
#MerckKGaA #BristolMyersSquibb #NovoNordisk #Teva
zurl.co/ZUTk2
The top 20 pharma companies by 2025 revenue
Boosted by a 45% increase in sales in 2025, Eli Lilly has jumped six notches in the annual top-20 revenue ranking, becoming the third-largest company in the biopharma industry. | 2025 was a solid year...
zurl.co
April 29, 2026 at 10:10 AM